Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ITOS:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2025 623.08M
March 31, 2025 658.87M
December 31, 2024 686.98M
September 30, 2024 723.08M
June 30, 2024 751.84M
March 31, 2024 629.77M
December 31, 2023 667.59M
September 30, 2023 677.64M
June 30, 2023 703.75M
March 31, 2023 728.35M
December 31, 2022 754.99M
Date Value
September 30, 2022 777.87M
June 30, 2022 814.77M
March 31, 2022 850.32M
December 31, 2021 884.71M
September 30, 2021 922.38M
June 30, 2021 318.68M
March 31, 2021 332.89M
December 31, 2020 344.56M
September 30, 2020 350.94M
June 30, 2020 145.21M
March 31, 2020 153.97M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ZimVie, Inc. (DELISTED) 758.22M
Sarepta Therapeutics, Inc. 3.189B
Black Titan Corp. 4.205M
Solid Biosciences, Inc. 420.58M
Replimune Group, Inc. 252.45M

Total Assets (Quarterly) Related Metrics